SCHEMBL8658476

SCHEMBL8658476

O=C1c2[c]cccc2C(=O)c2cc(O)ccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 8/20 0.60
ESR1 P03372 7/20 0.60
MAOA P21397 1/20 0.60
UGT1A1 P22309 1/20 0.60
MAOB P27338 1/20 0.60
TTR P02766 2/20 0.46
BCL2 P10415 3/20 0.44
MCL1 Q07820 3/20 0.44
ALDH1A1 P00352 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 1/20 0.42
STAT3 P40763 1/20 0.40
PTPRC P08575 1/20 0.39
ELANE P08246 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL136078 0.82 CDC25B (0.55) MAOAMAOBBCL2MCL1ALDH1A1
SCHEMBL5506572 0.82 CDC25B (0.55) MAOAMAOBBCL2MCL1ALDH1A1
SCHEMBL8657198 0.80 S100A4 (0.58) MAOBTTRBCL2MCL1ALDH1A1
2-Hydroxyanthraquinone SCHEMBL28843858 0.80 ESR1 (0.86) ESR2ESR1MAOAUGT1A1MAOB
2-Hydroxyanthraquinone SCHEMBL498619 0.80 ESR1 (0.86) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL3673942 0.80 CDC25B (0.41) MAOAMAOBMCL1ALDH1A1RAB9A
SCHEMBL143100 0.78 ESR1 (0.82) ESR2ESR1MAOAUGT1A1MAOB
2-Hydroxyanthraquinone SCHEMBL28853822 0.78 ESR1 (0.82) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL30366712 0.78 ESR1 (0.82) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL28320135 0.78 ESR1 (0.82) ESR2ESR1MAOAUGT1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807837-A ADMINISTERING TO TREAT HIV INFECTIONS TO INHIBIT THE REPLICATION OF FOREIGN NUCLEIC ACIDS IN A NORMAL CELL SANKYO COMPANY, LIMITED (JP) 1998-09-15 US disclosed
US-5674856-A TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS, INCLUDING AIDS AND TUMORS SANKYO COMPANY, LIMITED (JP) 1997-10-07 US disclosed
EP-0611075-B1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use SANKYO CO (JP) 1996-12-18 EP disclosed
EP-0611075-A1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-08-17 EP disclosed